Barriers to Eye Screening for People With Diabetes in India

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-01-24

Study Completion Date

2019-08-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Brief Summary: Diabetic retinopathy (DR) is a leading cause of visual impairment and has major public health implications globally and especially in countries such as India where the prevalence of diabetes is high. With timely screening and intervention, the disease progression to blindness can be prevented but several barriers exist to the provision of care. The long term aim is to identify the barriers to DR screening and to plan potential interventional strategies. From the qualitative study, the reasons such as lack of awareness or knowledge, distance to travel, lack of reminder system were identified as a reason for poor follow-up. This lead to the development of interventional strategies.

This was a randomized, investigator-masked clinical trial that was conducted in a tertiary eye care centre in South India. Consecutive patients with diabetes who were residents in Chennai and its vicinity of approximately 100 km radius and who were undergoing repeated intravitreal injections for DME were recruited into the trial. The aim of the study is to investigate the effect of SMS informational reminders among patients with Diabetic macular edema for the follow-up. They study consists of 2 groups, SMS reminder group receives the reminders 1 week and 2 days prior to the scheduled appointments with the concerned doctor on a particular date and time, whereas other group does not receive any reminders for the appointment schedule. After the follow-up, the patients will be screened for the attendance at the review visit.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparing the Compliance to Follow-up in Patients With Diabetic Macular Edema

NCT05019807

Diabetic Macular Edema

COMPLETED NA

Expansion of Integrated AI Solution for Diabetic Retinopathy Screening in Thailand

NCT05527535

Diabetic Retinopathy

UNKNOWN

Aflibercept anD navigateD vErsus coNvensional Laser in Diabetic macUlar edeMa

NCT02554747

Diabetic Macular Oedema

COMPLETED NA

The Sensitivity of Traditional Chinese Medical Diagnostic Tools for Diabetic Retinopathy Diabetic retinopathy-a Pilot Study

NCT04030611

Diabetic Retinopathy

UNKNOWN

Home Monitoring of Diabetic Macular Edema

NCT05223569

Macular Edema Due to Diabetes Mellitus

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetic Macular Edema

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SCREENING

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SMS reminder

This arm receive SMS reminder for the follow-up of DR Screening

Group Type OTHER

SMS reminder

Intervention Type OTHER

The group receives reminder for the follow-up at 1 week and 2 days prior to their scheduled appointments.

No SMS reminder

This arm did not receive SMS reminder for the follow-up of DR Screening

Group Type OTHER

No SMS reminder

Intervention Type OTHER

The group did not receives any SMS regarding scheduled appoinments.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SMS reminder

The group receives reminder for the follow-up at 1 week and 2 days prior to their scheduled appointments.

Intervention Type OTHER

No SMS reminder

The group did not receives any SMS regarding scheduled appoinments.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults with \> 40 years of age
* Diagnosed as centre involving Diabetic macular edema (DME)
* Patients who received intravitreal injections for DME
* Ability to give informed consent